CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29414259.
- Also identified by DOI 10.1146/annurev-med-012017-043208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antigen-specific CD8 T cells are central to the control of chronic infections and cancer, but persistent antigen stimulation results in T cell exhaustion. Exhausted CD8 T cells have decreased effector function and proliferative capacity, partly caused by overexpression of inhibitory receptors such as programmed cell death (PD)-1. Blockade of the PD-1 pathway has opened a new therapeutic avenue for reinvigorating T cell responses, with positive outcomes especially for patients with cancer. Other strategies to restore function in exhausted CD8 T cells are currently under evaluation-many in combination with PD-1-targeted therapy. Exhausted CD8 T cells comprise heterogeneous cell populations with unique differentiation and functional states. A subset of stem cell-like PD-1<sup>+</sup> CD8 T cells responsible for the proliferative burst after PD-1 therapy has been recently described. A greater understanding of T cell exhaustion is imperative to establish rational immunotherapeutic interventions.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Infections
- Neoplasms
- Programmed Cell Death 1 Receptor
- T-Lymphocyte Subsets